Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer Article

cited authors

  • Socinski, MA; Schell, MJ; Peterman, A; Bakri, K; Yates, S; Gitten, R; Unger, P; Lee, J; Lee, JH; Tynan, M; Moore, M; Kies, MS

authors

Publication Date

  • March 1, 2002

webpage

published in

category

start page

  • 1335

end page

  • 1343

volume

  • 20

issue

  • 5